Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ICOSLG anticorps (AA 19-256)

ICOSLG Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN6142131
  • Antigène Voir toutes ICOSLG Anticorps
    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
    Épitope
    • 9
    • 7
    • 7
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 19-256
    Reactivité
    • 70
    • 14
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 43
    • 28
    • 7
    • 1
    Lapin
    Clonalité
    • 40
    • 38
    • 1
    Polyclonal
    Conjugué
    • 47
    • 9
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ICOSLG est non-conjugé
    Application
    • 43
    • 36
    • 28
    • 14
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Séquence
    DTQEKEVRAM VGSDVELSCA CPEGSRFDLN DVYVYWQTSE SKTVVTYHIP QNSSLENVDS RYRNRALMSP AGMLRGDFSL RLFNVTPQDE QKFHCLVLSQ SLGFQEVLSV EVTLHVAANF SVPVVSAPHS PSQDELTFTC TSINGYPRPN VYWINKTDNS LLDQALQNDT VFLNMRGLYD VVSVLRIART PSVNIGCCIE NVLLQQNLTV GSQTGNDIGE RDKITENPVS TGEKNAAT
     Réactivité croisée
    Humain, Souris, Rat
    Attributs du produit
    Polyclonal Antibodies
    Purification
    Affinity purification
    Immunogène
    Recombinant fusion protein containing a sequence corresponding to amino acids 19-256 of human ICOSL (NP_056074.1).
    Isotype
    IgG
    Top Product
    Discover our top product ICOSLG Anticorps primaire
  • Indications d'application
    WB,1:500 - 1:2000,IHC,1:50 - 1:200
    Commentaires

    HIGH QUALITY

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
    Autre désignation
    ICOSLG (ICOSLG Produits)
    Synonymes
    anticorps ICOSLG, anticorps AU044799, anticorps B7-H2, anticorps B7RP-1, anticorps B7h, anticorps BG071784, anticorps GI50, anticorps GL50, anticorps GL50-B, anticorps ICOS-L, anticorps Icoslg, anticorps LICOS, anticorps Ly115l, anticorps mKIAA0653, anticorps B7H2, anticorps B7RP1, anticorps CD275, anticorps ICOSL, anticorps Icosl, anticorps RGD1562791, anticorps inducible T-cell costimulator ligand, anticorps icos ligand, anticorps inducible T-cell co-stimulator ligand, anticorps ICOSLG, anticorps Icosl, anticorps Icoslg
    Sujet
    Inducible co-stimulator ligand (ICOSL), also known as B7-H2, is a member of the B7 family of co-stimulatory molecules related to B7-1 and B7-2. It is a transmembrane glycoprotein with extracellular IgV and IgC domains, and binds to ICOS on activated T cells, thus delivers a positive costimulatory signal for optimal T cell function. The structural features of ICOSL are crucial for its costimulatory function. Present study shows that ICOSL displays a marked oligomerization potential, resembling more like B7-1 than B7-2. B7-H2-dependent signaling may play an active role in a proliferative response rather than in cytokine and chemokine production. The CD28/B7 and ICOS/B7-H2 pathways are both critical for costimulating T cell immune responses. Deficiency in either pathway results in defective T cell activation, cytokine production and germinal center formation.,ICOSLG,B7-H2,B7H2,B7RP-1,B7RP1,CD275,GL50,ICOS-L,ICOSL,LICOS,Immunology & Inflammation,CD markers,ICOSLG
    Poids moléculaire
    20 kDa/33 kDa/34 kDa
    ID gène
    23308
    UniProt
    O75144
    Pathways
    Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Vous êtes ici:
Support technique